共 34 条
[1]
Delongchamps N.B., Peyromaure M., The role of vascular endothelial growth factor in kidney and prostate cancer, Can J Urol, 14, 5, pp. 3669-3677, (2007)
[2]
Sgadari C., Barillari G., Toschi E., Et al., HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma, Nat Med, 8, 3, pp. 225-232, (2002)
[3]
Gulley M.L., Tang W., Laboratory assays for Epstein-Barr virus-related disease, J Mol Diagn, 10, 4, pp. 279-292, (2008)
[4]
Raab-traub N., Flynn K., Pearson G., Et al., The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA, Int J Cancer, 39, 1, pp. 25-29, (1987)
[5]
Guang-wu H., Sunagawa M., Jie-en L., Et al., The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma, Laryngoscope, 110, 12, pp. 2066-2069, (2000)
[6]
Khabir A., Karray H., Rodriguez S., Et al., EBV latent membrane protein 1 abundance correlates with patient age but not with metastatic behavior in north African nasopharyngeal carcinomas, Virol J, 2, (2005)
[7]
Kwok Fung Lo A., Liu Y., Wang X., Et al., Identification of downstream target genes of latent membrane protein 1 in nasopharyngeal carcinoma cells by suppression subtractive hybridization, Biochim Biophys Acta, 1520, 2, pp. 131-140, (2001)
[8]
Brahimi-horn C., Pouyssegur J., The role of the hypoxia-inducible factor in tumor metabolism growth and invasion, Bull Cancer, 93, 8, (2006)
[9]
Hui E.P., Chan A.T., Pezzella F., Et al., Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival, Clin Cancer Res, 8, 8, pp. 2595-2604, (2002)
[10]
Glaser S.L., Hsu J.L., Gulley M.L., Epstein-Barr virus and breast cancer: State of the evidence for viral carcinogenesis, Cancer Epidemiol Biomarkers Prev, 13, 5, pp. 688-697, (2004)